Lumos Pharma, Inc. (LUMO) Financials

Stock symbol LUMO is outdated, potentially delisted? Maybe it is available on other exchange?

LUMO Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2024	17.5 million	12.5 million
June 30, 2024	21.4 million	11.1 million
March 31, 2024	28.1 million	10.6 million
Dec. 31, 2023	40.6 million	13.3 million

LUMO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2024	-5.0 million	379000
June 30, 2024	-6.4 million	387000
March 31, 2024	-12.9 million	580000
Dec. 31, 2023	-20.6 million	524000

LUMO Net Income

No data available :(

LUMO Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2024	13.5 million	-	-
June 30, 2024	16.8 million	145000	449000
March 31, 2024	23.2 million	225000	518000
Dec. 31, 2023	36.1 million	303000	585000

LUMO Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2024	8.3 million
June 30, 2024	8.1 million
March 31, 2024	8.1 million
Dec. 31, 2023	8.1 million

LUMO Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2024	-	4.2 million	4.2 million	-
June 30, 2024	-	4.6 million	3.7 million	-2000
March 31, 2024	13.2 million	7.2 million	3.8 million	-2000
Dec. 31, 2023	13.2 million	6.7 million	4.2 million	-18000

LUMO Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2024	726000	-
June 30, 2024	488000	2000
March 31, 2024	165000	2000
Dec. 31, 2023	826000	18000

LUMO Revenue by Segment

Graph available only for paid members. Upgrade to see it.

LUMO

Price: $4.34

52 week price:

1.37

4.58

Earnings Per Share: -4.28 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 22134

Market Capitalization: 37.5 million

Links:

LUMO on Yahoo Finance